Clinical Trial Update: Defining the Role of Insulin Resistance in 'Idiopathic' Dilated Cardiomyopathy [NA]

View source ↗

Summary

A Stanford-sponsored clinical trial investigating the role of insulin resistance in idiopathic dilated cardiomyopathy was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dilated Cardiomyopathy
• Idiopathic Dilated Cardiomyopathy

Snippet

Sponsor: Stanford University | Conditions: Dilated Cardiomyopathy | NA | Status: TERMINATED